CLARITEV CORPORATION Interest Expense
CLARITEV CORPORATION (CTEV) reported Interest Expense of $82.20 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-09
- CLARITEV CORPORATION interest expense for the quarter ending 2024-03-31 was $82.20M, a 1.47% decline year-over-year.
- CLARITEV CORPORATION interest expense for the quarter ending 2023-12-31 was $83.00M, a 1.01% increase year-over-year.
- CLARITEV CORPORATION interest expense for the quarter ending 2023-09-30 was $84.30M, a 9.36% increase year-over-year.
- CLARITEV CORPORATION interest expense for the quarter ending 2023-06-30 was $82.47M, a 13.45% increase year-over-year.
- CLARITEV CORPORATION interest expense for fiscal 2023 was $333.21M, a 9.82% increase from fiscal 2022.
- CLARITEV CORPORATION interest expense for fiscal 2022 was $303.40M, a 13.43% increase from fiscal 2021.
- CLARITEV CORPORATION interest expense for fiscal 2021 was $267.48M, a 20.31% decline from fiscal 2020.
- CLARITEV CORPORATION interest expense for fiscal 2020 was $335.64M, a 10.82% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $82.20M 10-Q · filed 2024-05-09 | $165.20M derived: sum of 2 quarters · filed 2024-05-09 | $249.50M derived: sum of 3 quarters · filed 2024-05-09 | $331.98M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | $83.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $167.31M derived: sum of 2 quarters · filed 2024-02-29 | $249.78M derived: sum of 3 quarters · filed 2024-02-29 | $333.21M 10-K · filed 2024-02-29 |
| 2023-09-30 | $84.30M 10-Q · filed 2023-11-08 | $166.78M derived: sum of 2 quarters · filed 2023-11-08 | $250.20M 10-Q · filed 2023-11-08 | $332.38M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-06-30 | $82.47M 10-Q · filed 2023-08-03 | $165.90M 10-Q · filed 2023-08-03 | $248.08M derived: sum of 3 quarters · filed 2024-05-09 | $325.16M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-03-31 | $83.43M 10-Q · filed 2024-05-09 | $165.60M derived: sum of 2 quarters · filed 2024-05-09 | $242.69M derived: sum of 3 quarters · filed 2024-05-09 | $315.38M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $82.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $159.26M derived: sum of 2 quarters · filed 2024-02-29 | $231.96M derived: sum of 3 quarters · filed 2024-02-29 | $303.40M 10-K · filed 2024-02-29 |
| 2022-09-30 | $77.09M 10-Q · filed 2023-11-08 | $149.78M derived: sum of 2 quarters · filed 2023-11-08 | $221.23M 10-Q · filed 2023-11-08 | $293.47M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $72.70M 10-Q · filed 2023-08-03 | $144.14M 10-Q · filed 2023-08-03 | $216.38M derived: sum of 3 quarters · filed 2024-02-29 | $283.89M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $71.44M 10-Q · filed 2023-05-10 | $143.69M derived: sum of 2 quarters · filed 2024-02-29 | $211.20M derived: sum of 3 quarters · filed 2024-02-29 | $275.20M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $72.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $139.75M derived: sum of 2 quarters · filed 2024-02-29 | $203.76M derived: sum of 3 quarters · filed 2024-02-29 | $267.48M 10-K · filed 2024-02-29 |
| 2021-09-30 | $67.51M 10-Q · filed 2022-11-09 | $131.52M derived: sum of 2 quarters · filed 2022-11-09 | $195.23M 10-Q · filed 2022-11-09 | $271.58M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $64.00M 10-Q · filed 2022-08-05 | $127.72M 10-Q · filed 2022-08-05 | $204.07M derived: sum of 3 quarters · filed 2023-03-01 | $286.34M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $63.72M 10-Q · filed 2022-05-10 | $140.06M derived: sum of 2 quarters · filed 2023-03-01 | $222.34M derived: sum of 3 quarters · filed 2023-03-01 | $308.39M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $76.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $158.62M derived: sum of 2 quarters · filed 2023-03-01 | $244.67M derived: sum of 3 quarters · filed 2023-03-01 | $335.64M 10-K · filed 2023-03-01 |
| 2020-09-30 | $82.28M 10-Q · filed 2021-11-04 | $168.32M derived: sum of 2 quarters · filed 2021-11-04 | $259.29M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $86.05M 10-Q · filed 2021-08-06 | $177.01M 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $90.97M 10-Q · filed 2021-05-14 | |||
| 2019-12-31 | $376.35M 10-K · filed 2022-02-25 | |||
| 2018-12-31 | $383.26M 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rimini Street, Inc. (RMNI) | United States | $0.401B | 54.39 |
| Advantage Solutions Inc. (ADV) | United States | $0.435B | -2.00 |
| International Money Express, Inc. (IMXI) | United States | $0.320B | 23.44 |
| Outdoor Holding Co (POWW) | United States | $0.270B | 40.73 |
| CONDUENT Inc (CNDT) | United States | $0.253B | -1.00 |
| DHI GROUP, INC. (DHX) | United States | $0.205B | 132.15 |
| Phreesia, Inc. (PHR) | United States | $0.621B | 63.46 |
| TEN Holdings, Inc. (XHLD) | United States | $0.152B | |
| Priority Technology Holdings, Inc. (PRTH) | United States | $0.643B | 9.77 |
| OptimizeRx Corp (OPRX) | United States | $0.149B | 23.33 |